TABLE 2.
Ex vivo SIV-specific CD8+ T cells used in the 48-h virus suppression assay
| Epitope | Protein | Amino acid positions | Sequence | MHC restriction | IC50 (nM) |
|---|---|---|---|---|---|
| SL8 | Tat | 28-35 | STPESANL | A*01 | 43a |
| RL10 | Nef | 137-146 | RRHRILDIYL | B*08 | 11b |
| YY9 | Nef | 159-167 | YTSGPGIRY | A*02 | 2.7c |
| KL9 | Rev | 12-20 | KRLRLIHLL | B*08 | 3.2b |
| KF9 | Env gp41 | 524-532 | KRGVFVLGF | B*08 | 7.2b |
| KL9 | Env gp41 | 573-581 | KRQQELLRL | B*08 | 12b |
| TL9 | Env gp41 | 620-628 | TVPWPNASL | A*01 | 10d |
| RL9 | Env gp41 | 868-876 | RRIRQGLEL | B*08 | 5.5b |
| GY9 | Gag p17 matrix | 71-79 | GSENLKSLY | A*02 | 4.9c |
| CM9 | Gag p27 capsid | 181-189 | CTPYDINQM | A*01 | 22a |
| RL9 | Vif | 123-131 | RRAIRGEQL | B*08 | 7.5b |
| RL8 | Vif | 172-179 | RRDNRRGL | B*08 | 152b |